Figures & data
Table I. Number of individuals observed: (a) in each combination of data-sources per demographic cross-classification; (b) by each demographic characteristic (GGC = Greater Glasgow & Clyde; Rest = rest of Scotland), or data-source (DS1 = social enquiry reports; DS2 = hospital records; DS3 = drug treatment agencies; DS4 = recent HCV diagnoses)
Figure 1. Posterior probability distribution for Scotland's number of current injectors in 2006: by using all four data sources and by using three only.
![Figure 1. Posterior probability distribution for Scotland's number of current injectors in 2006: by using all four data sources and by using three only.](/cms/asset/d101d9b6-3fe8-4db0-b264-36f0c6c913ba/iart_a_706344_f0001_b.gif)
Table II. Posterior median [mean] and 95% “symmetric” CI rounded to nearest 100 for number of current IDUs, overall and per-stratum: M = male, F = female; 15–34 and 35 + denote age-groups
Table III. Posterior median [mean] and 95% “symmetric” CI rounded to nearest 100 for the number of current IDUs per gender and age-group stratum in 2000, 2003, and 2006: 15–34 and 35+ denote the age-groups
Table IV. Posterior median [mean] and 95% “symmetric” CI by gender and age-group stratum for the annual opiate-related DRD rate per 100 current IDUs in 2006 – all 4 data-sources in play
Table V. Posterior median [mean] and 95% “symmetric” CI by gender and age-group stratum for the annual opiate-related DRD rate per 100 current IDUs in 2006 – after exclusion of recent HCV diagnoses (data-source DS4)
Table A1. Posterior probability of each two-way interaction, with its posterior mean (standard deviation) when present.
Table A2. Having excluded DS4 (recent HCV diagnoses) as data-source, posterior probability of each two-way interaction, with its posterior mean (standard deviation) when present. DS1 = social enquiry reports; DS2 = hospital records; DS3 = drug treatment agencies